An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function: Erratum : Transplantation

Journal Logo

Erratum

An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function: Erratum

Author Information
doi: 10.1097/TP.0000000000004370
  • Free

In the article “An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function” by Huang et al, which published online ahead of print on August 1, 2022, in Transplantation, an error was discovered by the authors in the following sentence:

Despite the possibility that subclinical rejections may not have been detected, eGFR over a median 543 (IQR 385–6547) d follow-up was stable.

The correct sentence should read:

Despite the possibility that subclinical rejections may not have been detected, eGFR over a median 543 (IQR 385–657) d follow-up was stable.

The authors apologize for the error.

REFERENCE

Huang E, Haas M, Gillespie M, et al. An assessment of the value of donor-derived cell-free DNA surveillance in patients with preserved kidney allograft function. Transplantation. [Epub ahead of print. August 1, 2022]. doi: 10.1097/TP.0000000000004267.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.